DK120337B - Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.

Info

Publication number
DK120337B
DK120337B DK319165AA DK319165A DK120337B DK 120337 B DK120337 B DK 120337B DK 319165A A DK319165A A DK 319165AA DK 319165 A DK319165 A DK 319165A DK 120337 B DK120337 B DK 120337B
Authority
DK
Denmark
Prior art keywords
androstane
keto
halogen
preparation
therapeutically active
Prior art date
Application number
DK319165AA
Other languages
Danish (da)
English (en)
Inventor
P Westerhof
J Hartog
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB291965A external-priority patent/GB1139411A/en
Priority claimed from CH846564A external-priority patent/CH454842A/de
Application filed by Philips Nv filed Critical Philips Nv
Publication of DK120337B publication Critical patent/DK120337B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK319165AA 1965-01-22 1965-06-23 Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. DK120337B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB291965A GB1139411A (en) 1965-01-22 1965-01-22 Preparation of 10-‡-methyl steroids
CH846564A CH454842A (de) 1965-05-31 1965-05-31 Verfahren zur Herstellung von neuen 9B,10a-Steroiden

Publications (1)

Publication Number Publication Date
DK120337B true DK120337B (da) 1971-05-17

Family

ID=25703347

Family Applications (2)

Application Number Title Priority Date Filing Date
DK319165AA DK120337B (da) 1965-01-22 1965-06-23 Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken.
DK324365AA DK123352B (da) 1965-01-22 1965-06-25 Analogifremgangsmåde til fremstilling af 6-halogensubstituerede 9β, 10α-steroider af androstanrækken.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK324365AA DK123352B (da) 1965-01-22 1965-06-25 Analogifremgangsmåde til fremstilling af 6-halogensubstituerede 9β, 10α-steroider af androstanrækken.

Country Status (14)

Country Link
US (2) US3423433A (US20080094685A1-20080424-C00004.png)
AT (1) AT261129B (US20080094685A1-20080424-C00004.png)
BE (2) BE665762A (US20080094685A1-20080424-C00004.png)
BR (1) BR6570589D0 (US20080094685A1-20080424-C00004.png)
CH (1) CH464188A (US20080094685A1-20080424-C00004.png)
DE (2) DE1518994A1 (US20080094685A1-20080424-C00004.png)
DK (2) DK120337B (US20080094685A1-20080424-C00004.png)
ES (1) ES314639A1 (US20080094685A1-20080424-C00004.png)
FI (1) FI41743B (US20080094685A1-20080424-C00004.png)
FR (3) FR4631M (US20080094685A1-20080424-C00004.png)
GB (1) GB1087920A (US20080094685A1-20080424-C00004.png)
IL (2) IL23629A (US20080094685A1-20080424-C00004.png)
NL (2) NL6508179A (US20080094685A1-20080424-C00004.png)
SE (1) SE331277B (US20080094685A1-20080424-C00004.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667121A (US20080094685A1-20080424-C00004.png) * 1964-10-28
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof
GB1228801A (US20080094685A1-20080424-C00004.png) * 1967-07-11 1971-04-21
US3937700A (en) * 1970-03-04 1976-02-10 U.S. Philips Corporation Novel 1,2-methylene-17α-acyloxy (or improved hydroxy)-9β, 10α-steroid compounds of the pregnane series, pharmaceutic preparations on the basis of the novel compounds and methods of producing said compounds and preparations
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US20070082876A1 (en) * 2005-09-30 2007-04-12 Solvay Pharmaceuticals Gmbh Novel C18 modified retrosteroids as progesterone receptor modulator compounds
US20070212751A1 (en) * 2006-01-18 2007-09-13 Solvay Pharmaceuticals Gmbh Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL252417A (US20080094685A1-20080424-C00004.png) * 1959-06-08
US3258473A (en) * 1963-10-04 1966-06-28 Syntex Corp 17-dihaloacetate esters of 17alpha-hydroxy-21-desoxypregnane derivatives
IL23629A (en) * 1965-01-22 1969-01-29 Hoffmann La Roche 9beta,10alpha-steroids and process for the manufacture thereof

Also Published As

Publication number Publication date
BR6570589D0 (pt) 1973-08-02
IL23785A (en) 1969-09-25
AT261129B (de) 1968-04-10
ES314639A1 (es) 1966-02-16
BE665762A (US20080094685A1-20080424-C00004.png) 1965-12-22
FR1439514A (fr) 1966-05-20
IL23629A (en) 1969-01-29
DK123352B (da) 1972-06-12
SE331277B (US20080094685A1-20080424-C00004.png) 1970-12-21
GB1087920A (en) 1967-10-18
DE1543274A1 (de) 1969-07-24
US3304314A (en) 1967-02-14
CH464188A (de) 1968-10-31
FR1446515A (fr) 1966-07-22
DE1518994A1 (de) 1969-09-25
NL6508179A (US20080094685A1-20080424-C00004.png) 1965-12-27
FR4631M (US20080094685A1-20080424-C00004.png) 1966-11-28
US3423433A (en) 1969-01-21
BE666060A (US20080094685A1-20080424-C00004.png) 1965-12-28
NL6508148A (US20080094685A1-20080424-C00004.png) 1966-06-27
FI41743B (US20080094685A1-20080424-C00004.png) 1969-10-31

Similar Documents

Publication Publication Date Title
DK116128B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17α-(alkanoyloxy eller cycloalkanoyloxy)-21-(alkanoyloxy eller cycloalkanoyloxy)-16β-methyl-9α-halogen-11β-hydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK129835B (da) Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner.
DK129701B (da) Fremgangsmåde til fremstilling af steroider af androstanrækken.
DK107871C (da) Fremgangsmåde til fremstilling af 2-alkyl-3-oxo-10α-methylsteroider af androstan- eller pregnanrækken.
DK116207B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-steroider af pregnanrækken.
DK120337B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 3-keto-6-halogen-9β10α-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK120190B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive 17-estere af 9α,11β-dihalogen-16α-alkyl-Δ&lt;1,4&gt;-pregnadien-17α,21-diol-3,20-dioner.
DK114060B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK119764B (da) Fremgangsmåde til fremstilling af 3-spiro-3&#39;-diaziridin- eller diazirinsteroider af androstan- eller estranrækken.
DK115472B (da) Fremgangsmåde til fremstilling af 11-hydroxylerede steroider af pregnanrækken.
DK115989B (da) Fremgangsmåde til fremstilling af Δ&lt;5(10)&gt;-3-keto-19-nor-steroider af androstan- og pregnanrækken.
DK126647B (da) Analogifremgangsmåde til fremstilling af 16α,17α-(substitueret-methylen)-steroider af pregnanrækken.
DK124539B (da) Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ&lt;1,4&gt;-steroider af pregnan- eller androstanrækken.
DK111141B (da) Fremgangsmåde til fremstilling af 2&#39;-acetamido-2&#39;-desoxyglucosider eller -galactosider af 17α,21-dihydroxy-11-oxygenerede -3,20-diketo-steroider af pregnanrækken.
DK103018C (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;4,6&gt;-steroider af androstan- eller pregnanrækken.
DK119657B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-21-hydroxy-steroider af pregnanrækken.
DK113146B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 6-halogen-1α,2α-methylen-16α-methyl-&amp;Delta&lt;4,6&gt;-pregnadien-17α-ol-3,20-dioner eller deres 17-estere.
DK113920B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 21-(β-ethoxy-ethoxy)-acetater eller 21-(β-ethoxy-β-ethoxy-ethoxy)-acetater af steroider af pregnanrækken.
DK117350B (da) Fremgangsmåde til fremstilling af 11β-hydroxy-17α-acyloxy-steroider af pregnan-rækken.
DK118461B (da) Fremgangsmåde til fremstilling af 6-halogen- eller -alkylsubstituerede 4-chlor-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK132226B (da) Fremgangsmåde til fremstilling af 16alfa, 17alfa-dialkylsteroider af pregnanrækken.
DK122452B (da) Analogifremgangsmåde til fremstilling af 21-estere af 6α-halogen-16α-methyl-Δ&lt;1,4&gt;-pregnadien-11β,21-diol-3,20-dioner.
DK124128B (da) Fremgangsmåde til fremstilling af 4-oxo-19-nor-A-homo-Δ&lt;1,5(10)&gt;-steroid-diener af androstan-, pregnan- eller cholestanrækken.
DK132121B (da) Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion.
DK126649B (da) Analogifremgangsmåde til fremstilling af 18-methylensteroider af pregnan- eller 19-nor-pregnanrækken.